Lv2
134 积分 2023-12-02 加入
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
6天前
已完结
The side effects of platinum-based chemotherapy drugs: a review for chemists
8天前
已完结
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
24天前
已完结
Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation
24天前
已完结
Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus
24天前
已完结
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma
25天前
已完结
Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study
1个月前
已完结
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
1个月前
已完结
Mechanisms of drug resistance in HCC
1个月前
已完结
Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma
1个月前
已完结
皖公网安备34019202002308
